Medicare Enrolled

Dr. Barbara Leighton, MD

Pulmonary Disease · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
3998 RED LION RD, Philadelphia, PA 19114
2156128500
In practice since 2006 (19 years)
NPI: 1487751475 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Leighton from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Leighton? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Leighton

Dr. Barbara Leighton is a pulmonary disease specialist in Philadelphia, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Leighton performed 647 Medicare services across 480 unique beneficiaries.

Between the years covered by Open Payments, Dr. Leighton received a total of $11,272 from 43 pharmaceutical and/or device companies across 555 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Leighton is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 49% volume in PA $11,272 industry payments

Medicare Practice Summary

Medicare Utilization ↗
647
Medicare services
Top 49% in PA for pulmonary disease
480
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~34 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
233 $64 $130
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
149 $95 $275
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
75 $140 $360
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
55 $103 $245
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
45 $94 $190
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
35 $130 $350
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
23 $67 $190
Hospital follow-up visit, low complexity
Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service.
18 $36 $75
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
14 $134 $350
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,272
Total received (2018-2024)
Avg $1,610/year across 7 years
Top 17% in PA for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
555
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$10,925 (96.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$347 (3.1%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,063
2023
$2,015
2022
$1,833
2021
$1,279
2020
$1,374
2019
$1,532
2018
$1,176

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$559
Regeneron Healthcare Solutions, Inc.
$190
JAZZ PHARMACEUTICALS INC.
$167
GlaxoSmithKline, LLC.
$155
Boehringer Ingelheim Pharmaceuticals, Inc.
$139
HARMONY BIOSCIENCES LLC
$138
GENZYME CORPORATION
$97
Actelion Pharmaceuticals US, Inc.
$83
Takeda Pharmaceuticals U.S.A., Inc.
$80
United Therapeutics Corporation
$54
Inspire Medical Systems, Inc.
$53
Amgen Inc.
$41
Daiichi Sankyo Inc.
$37
Insmed, Inc.
$35
Mylan Specialty L.P.
$34
Genentech USA, Inc.
$33
INOGEN, INC.
$29
Axsome Therapeutics, Inc.
$27
Teleflex LLC
$23
Electromed, Inc.
$21
Phadia US Inc.
$21
Pulmonx Corporation
$17
IMMUNITYBIO, INC.
$16
Philips North America LLC
$15
Top 3 companies account for 44.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,605
GlaxoSmithKline, LLC.
$1,944
Boehringer Ingelheim Pharmaceuticals, Inc.
$1,016
Actelion Pharmaceuticals US, Inc.
$622
GENZYME CORPORATION
$521
Regeneron Healthcare Solutions, Inc.
$488
Insmed, Inc.
$412
JAZZ PHARMACEUTICALS INC.
$399
Mylan Specialty L.P.
$293
United Therapeutics Corporation
$292
Takeda Pharmaceuticals U.S.A., Inc.
$231
HARMONY BIOSCIENCES LLC
$208
Amgen Inc.
$193
Genentech USA, Inc.
$193
Janssen Pharmaceuticals, Inc
$160
Mallinckrodt Hospital Products Inc.
$151
Sunovion Pharmaceuticals Inc.
$147
Philips Electronics North America Corporation
$139
Electromed, Inc.
$131
Shire North American Group Inc
$111
Grifols USA, LLC
$95
Novartis Pharmaceuticals Corporation
$79
Inspire Medical Systems, Inc.
$78
SANOFI-AVENTIS U.S. LLC
$75
Merck Sharp & Dohme Corporation
$74
Advanced Respiratory, Inc
$72
Bayer HealthCare Pharmaceuticals Inc.
$62
Daiichi Sankyo Inc.
$59
Jazz Pharmaceuticals Inc.
$56
Axsome Therapeutics, Inc.
$55
Pulmonx Corporation
$42
Teva Pharmaceuticals USA, Inc.
$40
Harmony Biosciences LLC
$39
INOGEN, INC.
$29
Teleflex LLC
$23
Phadia US Inc.
$21
ANI Pharmaceuticals, Inc.
$20
Merck Sharp & Dohme LLC
$19
Mallinckrodt Enterprises LLC
$17
PFIZER INC.
$17
IMMUNITYBIO, INC.
$16
ADVANCED RESPIRATORY, INC
$15
Philips North America LLC
$15
Top 3 companies account for 49.4% of all-time payments
Associated products mentioned in payments ›
(8874) inCourage · (AK6) Vest Therapy · ACTHAR · ADVAIR · AIRSUPRA · ANKTIVA · ANORO · ANORO ELLIPTA · ARALAST · AREXVY · ASMANEX · Adempas · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · BREZTRI AEROSPHERE · CHANTIX · CHARTIS CATHETER · CINQAIR · DUPIXENT · FASENRA · GLASSIA · INJECTAFER · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · INSPIRE · ImmunoCAP · KEYTRUDA · LONHALA MAGNAIR · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · PURIFIED CORTROPHIN GEL · Perforomist · Prolastin-C Liquid · REMODULIN · Respiratoriy Care Undiv · SMARTVEST · SPIRIVA · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TEZSPIRE · TRELEGY ELLIPTA · TYVASO · The Vest System Model 105 Home Care · UPTRAVI · UROLIFT · Utibron · Volara System · WAKIX · Wakix · Wellcentive Undiv · XARELTO · XOLAIR · XYREM · XYWAV · Xolair · Xyrem · YUPELRI · Yupelri · inCourage
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a pulmonary disease specialist in Philadelphia?
Compare pulmonary diseases in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
271
Per 100K population
17.1
County median income
$60,698
Nearest hospital
JEFFERSON HEALTH- NORTHEAST
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Leighton is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 17% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Leighton experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Leighton performed 233 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Leighton receive payments from pharmaceutical companies?
Yes. Dr. Leighton received a total of $11,272 from 43 companies across 555 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Leighton's costs compare to other pulmonary diseases in Philadelphia?
Dr. Leighton's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Leighton) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →